SOX9 and Hepatic fibrosis: In a study conducted by Adisasmita et al., dCas9-KRAB-based CRISPRi was employed to suppress SOX9 gene expression in chemically induced human hepatocyte progenitor cells (mCdHs) derived from human primary hepatocytes (hPHs) with the objective of treating liver fibrosis.